We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HOOD:NASDAQRobinhood Markets, Inc. Analysis

Data as of 2026-08-15 - not real-time

$95.56

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Robinhood Markets, Inc. is neutral at $95.56, with no clear ordering between short and long averages. It has lost 15.2% over the past 30 days. With RSI at 48.8 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $83.68 up to resistance at $108.21.
The shares look overvalued, trading on 44.0 times earnings above a sector average of 17.0. Consensus targets land 25.4% above where the shares trade now. Revenue is growing at 32.3% on a 42.0% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 57.6%, a beta of 3.00 and a maximum drawdown of 57.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

Robinhood Markets, Inc. NASDAQ:HOOD reported record quarterly revenue on July 29, 2026, and the stock faded anyway....Robinhood Markets Inc NASDAQ:HOOD has raised $225.Robinhood Markets, Inc. HOOD is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 97.26
  • MACD momentum is positive
  • 30-day price change of -15.2%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 44.0 versus sector average of 17.0
  • Trading below the 200-day average of 97.26
  • Analyst targets imply +25.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 44.0 versus sector average of 17.0
  • Analyst targets imply +25.4% versus the current price
  • Profit margin of 42.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth32.30%
Profit Margin42.01%
P/E Ratio44.0
ROE23.62%
ROA4.53%
Debt/Equity240.28
P/B Ratio9.1
Op. Cash Flow$245.0M
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI48.8
Support$83.68
Resistance$108.21
MA 20$94.87
MA 50$99.09
MA 200$97.26
MACDBullish
VolumeDecreasing
Fear & Greed Index95.98

Valuation

Fair Value$7.81
Target Price$119.82
Upside/Downside25.38%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.00
Volatility57.58%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.